What is the approximate cost of Crestor?
The cost of Crestor (rosuvastatin) can vary significantly depending on factors such as dosage, quantity, and insurance coverage. Without insurance, a 30-day supply of Crestor 10 mg tablets can range from approximately $170 to over $250 [1]. Prices may differ between pharmacies and online retailers [1].
How does insurance affect Crestor pricing?
Insurance plans can substantially lower the out-of-pocket cost for Crestor. Many insurance providers offer coverage for rosuvastatin, with co-pays often falling between $10 and $40 for a 30-day supply [1]. However, specific co-pay amounts depend on the individual insurance plan and its formulary. Some plans may require prior authorization or have preferred generic alternatives [1].
Are there less expensive alternatives to Crestor?
Yes, generic versions of rosuvastatin are available and are generally much more affordable than the brand-name Crestor [1]. For example, a 30-day supply of generic rosuvastatin 10 mg can cost as little as $10 to $30 without insurance [1]. Other statins, such as atorvastatin (Lipitor) or simvastatin (Zocor), are also available and may offer different pricing structures depending on whether they are brand-name or generic [2].
When does the patent for Crestor expire?
The primary patents for Crestor have already expired, allowing for the widespread availability of generic rosuvastatin [3]. The U.S. patent for rosuvastatin expired in mid-2016 [3]. This patent expiry paved the way for lower-cost generic versions to enter the market.
Who manufactures Crestor and its generics?
Brand-name Crestor was originally developed and marketed by AstraZeneca [4]. Following patent expiration, numerous pharmaceutical companies now produce generic rosuvastatin. These manufacturers can be found through pharmaceutical wholesale distributors and online pharmacies [1, 4].
What is Crestor used to treat?
Crestor is a statin medication prescribed to lower high cholesterol levels and triglycerides in the blood [4]. It is used to reduce the risk of heart attack and stroke in individuals with or without existing heart disease by lowering "bad" LDL cholesterol and raising "good" HDL cholesterol [4].